Savings Under Most-Favored-Nation Pricing for Prescription Drugs in Medicaid

JAMA 2026 Open access

Read full text
Authors: Thomas J. Hwang, Lisa Clemans-Cope, Aaron S. Kesselheim
DOI: 10.1001/jama.2026.9973
Cited by: 1
References: 4

Abstract

This study compares current Medicaid rebates with international reference prices and estimated potential savings under the Generating Cost Reductions for US Medicaid payment model.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Healthcare Policy and Management Medication Adherence and Compliance

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
336
Issue
6
Pages
514–514
Publication date
15 July 2026
Language
EN